BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37882962)

  • 21. Seropositive PLA2R-associated membranous nephropathy but biopsy-negative PLA2R staining.
    Luo J; Zhang W; Su C; Zhou Z; Wang G
    Nephrol Dial Transplant; 2021 Dec; 36(12):2216-2223. PubMed ID: 33236093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical value of renal phospholipase A2 receptor deposit in the prognosis evaluation and treatment options of idiopathic membranous nephropathy: A retrospective cohort study.
    Xie Z; Dong W; Li Z; Chen Y; Song L; Li R; Wu Y; Fu L; Liang H; Tao Y; Xie J; Wang W; Liu S; Ye Z; Shi W; Liang X
    Nephrology (Carlton); 2020 Mar; 25(3):219-229. PubMed ID: 31900967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy.
    Hoxha E; Kneißler U; Stege G; Zahner G; Thiele I; Panzer U; Harendza S; Helmchen UM; Stahl RA
    Kidney Int; 2012 Oct; 82(7):797-804. PubMed ID: 22673885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of PLA2R autoimmunity detected by measurement of anti-PLA2R antibodies combined with detection of PLA2R antigen in membranous nephropathy: A single-centre study over 14 years.
    Pourcine F; Dahan K; Mihout F; Cachanado M; Brocheriou I; Debiec H; Ronco P
    PLoS One; 2017; 12(3):e0173201. PubMed ID: 28257452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence, diagnostic value and clinical characteristics associated with the presence of circulating levels and renal deposits of antibodies against the M-type phospholipase A2 receptor in idiopathic membranous nephropathy.
    Segarra-Medrano A; Jatem-Escalante E; Quiles-Pérez MT; Salcedo MT; Arbós-Via MA; Ostos H; Valtierra N; Carnicer-Cáceres C; Agraz-Pamplona I
    Nefrologia; 2014 May; 34(3):353-9. PubMed ID: 24798555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monthly mini-dose rituximab for primary anti-PLA2R-positive membranous nephropathy: a personalized approach.
    Wang S; Deng Z; Wang Y; Bao W; Zhou S; Cui Z; Zheng D
    BMC Nephrol; 2023 May; 24(1):146. PubMed ID: 37237260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy.
    Svobodova B; Honsova E; Ronco P; Tesar V; Debiec H
    Nephrol Dial Transplant; 2013 Jul; 28(7):1839-44. PubMed ID: 23223223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and Histological Features of Phospholipase A2 Receptor-Associated and Thrombospondin Type-I Domain-containing 7A-Associated Idiopathic Membranous Nephropathy: A Single Center Retrospective Study from China.
    Zhang D; Zou J; Zhang C; Zhang W; Lin F; Jiang G
    Med Sci Monit; 2018 Jul; 24():5076-5083. PubMed ID: 30032157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN).
    Radice A; Trezzi B; Maggiore U; Pregnolato F; Stellato T; Napodano P; Rolla D; Pesce G; D'Amico M; Santoro D; Londrino F; Ravera F; Ortisi G; Sinico RA
    Autoimmun Rev; 2016 Feb; 15(2):146-54. PubMed ID: 26527329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases.
    Radice A; Pieruzzi F; Trezzi B; Ghiggeri G; Napodano P; D'Amico M; Stellato T; Brugnano R; Ravera F; Rolla D; Pesce G; Giovenzana ME; Londrino F; Cantaluppi V; Pregnolato F; Volpi A; Rombolà G; Moroni G; Ortisi G; Sinico RA
    J Nephrol; 2018 Apr; 31(2):271-278. PubMed ID: 29081027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Case of Pla2r and Exostosin 1 Positive Membranous Nephropathy - The Diagnostic and Therapeutic Dilemma.
    Sivagnanam H; Anand M; Senthikumar PK; Velu KB; Vishwanathan R
    Cureus; 2023 Aug; 15(8):e43619. PubMed ID: 37719621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Glomerular Mannose-Binding Lectin Deposition on the Prognosis of Idiopathic Membranous Nephropathy.
    Zhang Y; Liu Y; Liang L; Liu L; Tang X; Tang L; Chen P; Chen J; Wang Z; Cao W; Chen Q; Zhao N; Xu D
    Kidney Blood Press Res; 2020; 45(5):713-726. PubMed ID: 32894840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypercholesterolemia Correlates With Glomerular Phospholipase A2 Receptor Deposit and Serum Anti-Phospholipase A2 Receptor Antibody and Predicts Proteinuria Outcome in Idiopathic Membranous Nephropathy.
    Dong L; Li YQ; Guo SM; Xu G; Wei W; Han M
    Front Immunol; 2022; 13():905930. PubMed ID: 35784308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glomerular mannose-binding lectin deposition in intrinsic antigen-related membranous nephropathy.
    Hayashi N; Okada K; Matsui Y; Fujimoto K; Adachi H; Yamaya H; Matsushita M; Yokoyama H
    Nephrol Dial Transplant; 2018 May; 33(5):832-840. PubMed ID: 28992353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rare case of exostosin 1/exostosin 2-related membranous lupus nephritis concomitant with dual ANCA- and anti-GBM antibody-associated crescentic glomerulonephritis effectively diagnosed by mass spectrometry: a case report.
    Yamazaki T; Takahashi H; Takeuchi K; Sakamoto E; Tominaga K; Sakurabayashi S; Abe T; Sano T; Wada Y; Kuwahara N; Shimizu A; Takeuchi Y
    BMC Nephrol; 2023 Jul; 24(1):218. PubMed ID: 37488532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phospholipase A2 receptor staining in pediatric idiopathic membranous glomerulopathy.
    Cossey LN; Walker PD; Larsen CP
    Pediatr Nephrol; 2013 Dec; 28(12):2307-11. PubMed ID: 23903693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical implications of serum anti-PLA2R levels and glomerular PLA2R deposits in primary membranous nephropathy.
    Chaitanya Gunda K; Mathew GG; Balasubramanian S; Sunil Kumar KS
    G Ital Nefrol; 2024 Apr; 41(2):. PubMed ID: 38695230
    [No Abstract]   [Full Text] [Related]  

  • 38. Outcomes of primary membranous nephropathy based on serum anti-phospholipase A2 receptor antibodies and glomerular phospholipase A2 receptor antigen status: a retrospective cohort study.
    Yin P; Wang J; Liang W; Zhan L; Liu Y; Lin J; Chen X; He Y; Jian H; Xie Z; Tan X; Ye Q; Huang F
    Ren Fail; 2020 Nov; 42(1):675-683. PubMed ID: 32674643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined evaluation of glomerular phospholipase A2 receptor and immunoglobulin G subclass in membranous nephropathy.
    Ueki K; Tsuchimoto A; Matsukuma Y; Ataka E; Okamoto H; Tanaka S; Masutani K; Kitazono T; Nakano T
    Clin Kidney J; 2024 Jun; 17(6):sfae104. PubMed ID: 38854426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of phospholipase A2 receptor in primary membranous nephropathy: a systematic review and meta-analysis.
    Li W; Zhao Y
    Int Urol Nephrol; 2019 Sep; 51(9):1581-1596. PubMed ID: 31140029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.